Securing R&D Innovation by Booz Allen Hamilton

The increasing risk of cyber attacks against life sciences R&D functions, especially as the race for COVID-19 vaccines and therapies progresses, must be addressed to stay ahead of threats and enable R&D innovation. To stay ahead of threats and enable R&D innovation, organizations need to build a cohesive strategy around R&D Security. Join us for a panel discussion for perspectives on how to do so that you can apply for your organization.

Discussion will include:
– How to enable R&D innovation while maintaining security
– How to reduce risk to your R&D data and controls
– How to optimize your cybersecurity investment to get the greatest ROI when securing R&D assets
– Recommendations based on varying levels of security maturity
– An opportunity for Q&A between the presenters and the audience

Presented by Jim Ammons, Booz Allen Hamilton, Jamilia King, Eli Lilly, and Axel Wirth, MedCrypt.